Literature DB >> 24433593

Idiopathic anaphylaxis.

Phil L Lieberman1.   

Abstract

Idiopathic anaphylaxis is not uncommon and can be found in as many as 60% of patients referred to an allergist for anaphylactic events. It is an extremely frustrating condition for patients because they have no means of avoiding a known allergen and events occur spontaneously and unprovoked. The objective of this study was to synthesize and review the medical literature on idiopathic anaphylaxis and present a strategy for diagnosis, prevention, and treatment of episodes. A literature review was performed after a search of PubMed using the key words of idiopathic anaphylaxis. Idiopathic anaphylaxis is more common in adults than in children and in women than in men. The symptoms and signs are identical to those found in other causes of anaphylaxis. Perhaps the most common entities to be considered in the differential diagnosis are somatoform reactions. The two most recent advances in our ability to detect the cause are the discovery that episodes can be caused by mast cell-activating syndromes, systemic mastocytosis, and IgE to galactose-alpha-1,3-galactose. Patients experiencing idiopathic anaphylactic episodes should, if possible, avoid taking drugs that may complicate therapy or worsen a reaction. Fortunately, the vast majority of cases follow a benign course. Although many recurrent episodes of anaphylaxis remain idiopathic, recent advances in our knowledge, especially the description of mast cell-activating disorders and the discovery of anaphylactic reactions to galactose-α-1,3-galactose have allowed us to find causes in events that previously would have been classified as idiopathic. In addition, the majority of such patients exhibit a diminishing frequency of reactions over time and can be managed in a way that prevents mortality and a severe effect on their quality of life.

Entities:  

Mesh:

Year:  2014        PMID: 24433593     DOI: 10.2500/aap.2014.35.3717

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  6 in total

Review 1.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 2.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

3.  Perspectives on chronic urticaria/angioedema and its treatment.

Authors:  Joseph A Bellanti; Russell A Settiane
Journal:  Allergy Asthma Proc       Date:  2014 Jan-Feb       Impact factor: 2.587

4.  Omalizumab's role in the treatment of steroid dependent malignant idiopathic anaphylaxis.

Authors:  Öner Özdemir; Hayrunnisa Bekis Bozkurt; Bahri Elmas
Journal:  Turk Pediatri Ars       Date:  2017-06-01

Review 5.  Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists.

Authors:  Theo Gulen; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 6.  Idiopathic Anaphylaxis.

Authors:  Bright I Nwaru; Sangeeta Dhami; Aziz Sheikh
Journal:  Curr Treat Options Allergy       Date:  2017-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.